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Abstract
In this century, there are two mostly practiced techniques for bone regeneration. These are
autogenous bone grafting (ABG) and guided bone regeneration (GBR). It was reported in
the late 1970s that platelets have a good regenerative effects. Platelets include growth
factors that increase vascularization and collagen production by cell mitosis. Recently,
most of the studies have indicated that platelet-rich fibrin (PRF) is a great healing potential
for bony and soft tissue that derived from patients own blood. Most beneficial effects of
PRF are easily derived directly from patient’s venous blood without any ingredients, and
it has a great potential for hard and soft tissue regeneration. PRF has no inflammatory
effects and can be used with all kind of graft materials. When used as a membrane, it helps
protecting the surgical area to stimulate the healing of soft and bone tissues.
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1. Introduction
Platelet concentrates (PCs) for surgical use are innovative tools of regenerative medicine and
dentistry and were widely studied in oral and maxillofacial surgery. PCs are blood extracts,
applied to surgical sites, injuries, or wounds, a safe and effective way to promote soft tissue
healing and bone growth. The most frequently used substrate, platelet-rich fibrin (PRF) is a
member of platelet concentrates developed by Choukroun and colleagues [1]. PRF is an
autologous matrix, in which cytokines and cells are released after a short period [2].
The aim of this chapter is to describe the potential functions of PRF for bone grafting in oral
and maxillofacial surgery.
There are different types of PRF in local use.
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2. Pure platelet-rich fibrin (P-PRF)
Pure platelet-rich fibrin (P-PRF) in other terms leukocyte-poor platelet-rich fibrin is a prepara-
tion without leukocytes having a high-density fibrin network. This platelet concentrate exists
in a strongly activated gel form. It cannot be injected and used like traditional fibrin glues. On
the other hand, with its strong fibrin matrix facility, P-PRF can be handled like a real solid
material for several applications [3].
During preparation, only very low amounts of leucocytes are collected because of the specific
separator gel, which is used to obtain P-PRF. However, the platelet collection level is high, and
the preservation of the platelets during the procedure seems to be acceptable [4]. The main
disadvantage of this platelet concentrate protocol is its cost and complex procedure if it is
compared to the other forms of PRF, which are available nowadays [3].
3. Leukocyte and platelet-rich fibrin (L-PRF)
The second platelet concentrate type is leukocyte and platelet-rich fibrin (L-PRF), which is
known as leukocyte and platelet-rich fibrin concentrate, called Choukroun’s PRF. This product
was invented by Choukroun in 2000 [1, 2]. The main concept of this technique differs from
the other protocols. Patient’s blood is taken and immediately softly centrifuged. This provides
the formation of a fibrin clot in the middle of the tube, between the red blood cell base at the
bottom and the acellular plasma at the top. This clot includes nearly all the platelets and more
than 50% of the leukocytes from the initial blood harvest [5, 6]. The high quantity of leukocytes
provides immune and antibacterial properties, wound healing and growth factor regulation.
But, it depends on which leukocytes, in which quantity and in which state the centrifugation
process can softly activate the white blood cells [7]. This product therefore only exists in an
activated form and cannot be injected like a suspension. Therefore, L-PRF is a practical solid
material with strong fibrin scaffold and used in oral and maxillofacial surgery, periodontology,
implant dentistry and ear nose throat surgery [6].
4. Advanced platelet-rich fibrin (A-PRF)
The amount of WBCs effect vascularization and bone remodeling. As a result, researchers
made new modifications in the centrifugation speeds and times to prevent cell loss within the
PRF matrix [8]. These recent modifications of the PRF protocol have led to the improvement of
advanced platelet-rich fibrin (A-PRF), which uses lower G-forces to gain higher growth factors
compared to PRF [9]. It maintains higher amount of WBCs in the fibrin matrix and has special
glass tubes, which are designed to make clotting faster. After the centrifugation, the tubes are
removed and placed in their holders and left for 5 min to start clot formation. The fibrin clot
which is rich with WBCs provides higher growth factors and recent research emphasizes that
A-PRF enhances collagen matrix synthesis and supplement of progenitor cells [8].
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5. Injectable platelet-rich fibrin (i-PRF)
One of the recent developments in the PRF technology is injectable PRF (i-PRF). Standard
PRF is prepared as a gel which is inconvenient to inject [10]. i-PRF protocol necessitates
short centrifugation period in order to produce a liquid platelet concentrate, which includes
primarily liquid fibrinogen and thrombin prior to fibrin formation [11]. The plastic
tubes with hydrophobic surface are used, and therefore coagulation process does not effec-
tively start. Hence, all the blood components reach the top of the tube under the centrifuga-
tion force with short centrifugation time (i.e., 2–4 min). The light yellow-colored layer,
which is the combination of plasma and platelets, is aspirated from the top of the tube to
obtain i-PRF. Nowadays, it is used with bone grafts to keep graft particles tightly encapsu-
lated in the fibrin matrix. With the coagulation process, i-PRF forms a gel consistency
holding bone graft together. Also, the release of growth factor is beneficial for the graft.
This has the potential to convert any osteoconductive graft to osteopromotive, which would
provide faster and better bone formation. Another type of graft prepared with i-PRF is the
PRF block. For its preparation, i-PRF is mixed with a combination of bone graft and
shredded PRF clot [10].
6. Titanium prepared platelet-rich fibrin (T-PRF)
Some physicians worry about damage for the patient with glass-evacuated blood collection
tubes with silica activators. O’Connell emphasized that silica contact cannot be avoided with
glass tubes. These silica particles are dense enough to settle in the sediment and might reach
the patient when the product is used during procedures [12]. Recently, Tunali et al. used
medical grade titanium tubes to produce titanium prepared platelet-rich fibrin (T-PRF) [10].
This biocompatible material was tried to eliminate the potential negative effects of silica from
dry glass or glass-coated plastic tubes [12]. The research showed that T-PRF supply is a more
organized network than L-PRF. Furthermore, its fibrin network covers larger area and has
thicker fibrin clot. In a human study, wound healing in the palatal mucosa is found better with
the T-PRF application [10].
7. Prepared platelet-rich lysate (PRF-L)
A newer application of PRF is the prepared platelet-rich lysate (PRF-L). In this technique, after
PRF preparation, it is incubated at 37C in a humidified atmosphere of 5% CO2 and 95% air.
The exudate, which is collected, is referred to as PRF lysate. It is said to be a good source of
several growth factors. In a study, it is found that PRF-L can significantly improve the prolif-
eration index, collagen deposition and migration rates in chronically UVA-irradiated human
dermal fibroblasts [13]. This is a new technique that requires further studies.




Venous blood of patient is drawn into 10 mL, anticoagulant-free tubes and then immediately
spun in a tabletop centrifuge at 3000 rpm for 10 min. Due to the lack of anticoagulant, platelet
activation occurs once the blood contacts the glass tube walls and subsequently initiates the
coagulation cascade. By centrifugation, fibrinogen is concentrated in the top and middle of the
tube and then circulating thrombin transforms it into fibrin. This action leads to the development
of a fibrin clot in the middle of the tube, between the RBCs at the bottom and serum at the top.
The upper straw-colored layer is removed from the centrifuge tube and blotted to remove serum
and RBC to result in a dense matrix. Timing is also critical to the success of the PRF technique.
PRF must be prepared immediately before application to the surgical site (Figure 1) [1].
8.1. Clinical applications of PRF in oral surgery
In the past, PRF could be useful for both hemostasis and wound healing. Nowadays, sinus lift
technique is considered to be one of the most common and valid procedures for the use of PRF in
oral surgery. PRF is also used for augmenting the alveolar ridge, improve soft tissue healing and
periodontal regeneration and preserving the alveolar ridge height after extraction. It has been
studied that PRF improves wound healing in multiple extractions by reducing healing time [14].
Figure 1. Preparation of PRF membrane. A: Collection of venous blood into the tube; B: centrifuge device; C: platelet-rich
fibrin clots; D: PRF clots were pressed to obtain more dense membranes; E: PRF membranes.
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8.1.1. PRF in soft tissue regeneration
The use of platelet concentrates may reduce and control the risks associated with delayed bone
and soft tissue healing. The success for the healing of a bone graft is certainly related with
intact soft tissue coverage.
Patients using antiresorptive therapies exhibit a reduced healing potential in bone and soft tissue
that can lead to medication related osteonecrosis. In order to stimulate healing and obtain soft
tissue coverage, PRF can be placed to the surgical or exposed area without tension. Even if there
is a need for researches in this field, PRF presented valuable solutions till today [15].
The other indication of PRF usage is the method of socket preservation. When implant resto-
ration is considered after extraction of a tooth, this must be kept in mind that the resorption
process starts immediately. Thus, the volume of the socket, soft tissue closure and thickness of
gingiva must be protected as possible as early, for a complete and quick bone regeneration. If
the wound closure and remodeling are achieved properly, implant can be placed in the desired
position [15].
8.1.2. Guided bone regeneration (GBR) (as a barrier membrane)
Several oral and maxillofacial surgical procedures have used membranes for guided bone regen-
eration (GBR). The potential applications of PRF in this field have been shown to be effective in
different clinical situations. However, this method may not be superior as a barrier membrane
for regeneration when compared to conventional membranes, and therefore appropriate cases
should be selected in order to benefit from the properties of PRF in GBR (Figure 2) [16, 17].
8.1.3. Sinus lift procedure
Sinus lift is one of the most frequent grafting procedures in implantology and has proven to be
a successful and predictable technique for providing bone height for implant placement. In the
Figure 2. Enucleation of radicular cyst resulted from left central incisor tooth and apical resection were performed at the
same time. A: After eliminating the whole lesions, PRF placed into the intrabony defect to accelerate healing and prevent
soft tissue collapse. B and C: PRF membrane was used to cover the buccal wall of the cavity as a barrier.
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literature, no application using PRF was more studied than the sinus lift procedure. This model
generating to obtain bone height, provides a closed, protected and stable environment for
healing. Thus, bone healing in sinus cavity can be evaluated more accurate than the other
procedures that are in contact with the oral environment [18].
Subsinus cavity floored by the Schneiderian membrane following sinus lift has a capacity of
bone regeneration due to the high osteogenic properties, though several bone materials can
yield good results in terms of bone healing [19].
Most researches have focused on bone biomaterials to improve bone quality and to accelerate
healing for early operations. The main mechanism of subsinus cavity healing is to be filled
with blood clot that is promoting neoangiogenesis and proliferation. Similarly, the aim of using
PRF into the cavity is to provide space and optimize healing as a biologic agent [20]. The first
study reported on PRF by Choukroun et al. represented that the use of PRF in addition to the
bone grafts accelerated healing period for sinus floor augmentation [21]. It is important to
reduce healing time before implantation.
The incidence of perforation of the membrane that is a common intraoperative finding was
reported ranging from 10 to 60% [22]. The rupture of the membrane can lead to postoperative
complications, so has to be repaired before grafting. Otherwise, a biomaterial can migrate into
the sinus cavity leading to sinus infection and impairment of healing. Some biomaterials such
as collagen membrane and platelet concentrates have been commonly used to prevent these
complications. In addition to the use of PRF for grafting, it is also used as an adhesion material
and frequently preferred for repair of possible perforations of the schneiderian membrane
during sinus lift.
8.1.4. Grafting material for bone regeneration
The acceleration of healing in bone defect is of particular interest when dental implants would
be inserted in this area. Due to reduction of time, early functional loading and better primary
stability of the implant will be obtained after the regeneration [19]. Thus, some biologic agents
may be needed to shorten this period. For this purpose, PRF-like substances can be used. The
potential of these substances as a biologic agent in oral and maxillofacial surgery relies on the
growth factors stored within platelet alpha granules containing platelet-derived growth factor
(PDGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet-
derived angiogenic factor and transforming growth factor-beta (TGF-β). Moreover, PRF acts as
a biological connector between different graft elements and serves as a matrix that eases
forming new bone tissue into the defect. In fact, due to the lack of standardization and absence
of characterization of the studied PRF materials, it is difficult to explain the exact function of
platelet concentrates on bone regeneration [23].
8.1.5. PRF for peri-implant bone defects
Peri-implant bone defects are encountered as a result of peri-implantitis and secondly inade-
quate bone volume for implantation and thirdly immediate implantation. Although the mech-
anisms of peri-implantitis are considered to be bacterial accumulation or prosthetic overload of
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the implant, it is believed that the main mechanism of peri-implantitis is related to bone/
implant interface breakdown [24].
In case of small amount of bone, it is inevitable to make lateral perforation while placing
implant or bone resorption around particularly the collar of the implant. In order to reinforce
the bone amount around the implant to prevent resorption and gain more esthetic appearance,
autogenous and/or synthetic materials can be used to cover the open surface of these implants.
Peri-implant bone defects can be developed after immediate implantation (Figure 3). After the
insertion of the implant in a fresh avulsion socket, a large peri-implant defect must be filled
with a material to prevent soft tissue invagination [25].
For those three clinical situations, bone regeneration between the cavity/defect and implant
surface can be achieved by using PRF in addition to bone grafts. With its strong fibrin archi-
tecture and specific 3D cell distribution, especially L-PRF may offer positive results when used
Figure 3. Peri-implant bone defect after immediate implant placement. A: Buccal and palatinal bone defects around the
implant; B, C: A mix of PRF and xenogeneic bone graft constituted a sticky mass; D, E: PRF with bone graft placed into the
cavity; F: PRF membranes were used to cover the whole defect.
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in combination with bone biomaterials for the filling of peri-implant bone defects. On the
whole, there are still only few studies published in the literature about the use of L-PRF in
peri-implant bone defects [26].
9. In brief: advantages
• Eliminating transmission of diseases (the patient’s own blood)
• Promoting soft tissue healing
• Protection extraction socket against resorption and infection
• Minimal invasive and inexpensive method
• Role as a carrier matrix for bone grafts
• Supporting neoangiogenesis
• Minimal immunological reaction
• As a sticky material, holding different substances together
• Growth factors
10. Conclusion
PRF seems to be an accepted minimally invasive approach with good clinical results. With the
ease of preparation, low cost and biologic properties, PRF could be considered as a beneficial
treatment option. On the other hand, due to the lack of standardization and long-term follow
up clinical studies, the major effect of PRF on bone grafting has not been explained yet.
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